Cardax, Inc. (CDXI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: May 14, 2025
Cardax Revenue
Cardax had revenue of $104.57K in the quarter ending March 31, 2021, a decrease of -26.78%. This brings the company's revenue in the last twelve months to $500.71K, down -27.31% year-over-year. In the year 2020, Cardax had annual revenue of $538.95K, down -24.19%.
Revenue (ttm)
500.71K
Revenue Growth
-27.31%
P/S Ratio
0.00
Revenue / Employee
45.52K
Employees
11
Market Cap
83.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2020 | 538.95K | -172.00K | -24.19% |
| Dec 31, 2019 | 710.95K | -799.93K | -52.94% |
| Dec 31, 2018 | 1.51M | 900.55K | 147.55% |
| Dec 31, 2017 | 610.32K | 575.07K | 1,631.02% |
| Dec 31, 2016 | 35.26K | - | - |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |